A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation
Condition(s):Liver TransplantLast Updated:August 24, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Liver TransplantLast Updated:August 24, 2023Recruiting
Condition(s):Alveolar Bone ResorptionLast Updated:February 5, 2020Unknown status
Condition(s):Hematopoietic and Lymphoid Cell NeoplasmLast Updated:November 13, 2018Terminated
Condition(s):End Stage Renal DiseaseLast Updated:January 19, 2022Completed
Condition(s):High Model for End-Stage Liver Disease (MELD) ScoreLast Updated:October 21, 2019Withdrawn
Condition(s):Cardiac Surgery; CABGLast Updated:January 13, 2020Unknown status
Condition(s):Disease Due to BK Polyomavirus; Transplantation Infection; Disorder Related to TransplantationLast Updated:September 27, 2011Completed
Condition(s):Coronary Artery Disease; Myocardial InfarctionLast Updated:November 28, 2013Completed
Condition(s):Kidney Transplant; Complications; Frailty Syndrome; Depressive SyndromeLast Updated:October 27, 2023Recruiting
Condition(s):Stable Angina; Heart Failure; Atherosclerosis; Multivessel Coronary Artery DiseaseLast Updated:March 17, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.